Table 2.

Preprandial plasma glucose levels

Preprandial plasma glucose	Repaglinide and clopidogrel group	Mitiglinide and clopidogrel group	Repaglinide group
	(N = 15)	(N = 15)	(N = 15)
Breakfast
Before starting glinide	180.1 ± 35.5	161.8 ± 38.0	151.0 ± 20.9
After starting glinide	136.5 ± 44.1	150.1 ± 41.3	127.8 ± 33.0
Decrease in the amplitude of glycemic excursions	43.6 ± 33.6 *	11.6 ± 30.0	23.2 ± 23.7
Lunch
Before starting glinide	228.2 ± 48.6	231.7 ± 48.7	196.1 ± 32.3
After starting glinide	178.8 ± 69.8	177.2 ± 53.9	168.7 ± 37.2
Decrease in the amplitude of glycemic excursions	50.0 ± 36.6	55.8 ± 43.3	27.4 ± 38.9
Dinner
Before starting glinide	193.3 ± 54.5	190.5 ± 47.6	186.8 ± 56.5
After starting glinide	131.6 ± 43.4	165.9 ± 44.6	144.3 ± 52.8
Decrease in the amplitude of glycemic excursions	61.6 ± 49.3	24.6 ± 45.0	42.5 ± 38.9

Mean ± S.D., * p < 0.05 for the “repaglinide and clopidogrel group” versus the “mitiglinide and clopidogrel group”